Johnson & Johnson posted quarterly results on Tuesday that was above analysts’ expectations, thanks to robust demand for cancer medication Darzalex and its COVID-19 vaccination, despite the firm cutting its full-year adjusted profit outlook owing to a stronger currency. J&J joins… Read More ›